BACKGROUND Computational pathology uses deep learning (DL) to extract biomarkers from routine pathology slides. Large multicentric datasets improve performance, but such datasets are scarce for gastric cancer. This limitation could be overcome by Swarm Learning (SL). METHODS Here, we report the results of a multicentric retrospective study of SL for prediction of molecular biomarkers in gastric cancer. We collected tissue samples with known microsatellite instability (MSI) and Epstein-Barr Virus (EBV) status from four patient cohorts from Switzerland, Germany, the UK and the USA, storing each dataset on a physically separate computer. RESULTS On an external validation cohort, the SL-based classifier reached an area under the ...
Background: Globally, gastric cancer (GC) is the fifth most common tumor. It is necessary to identif...
Molecular alterations in cancer can cause phenotypic changes in tumor cells and their microenvironme...
Aim Gastric cancer (GC) is a tumor entity with highly variant outcomes. Lymph node metastasis is a ...
BACKGROUND: Computational pathology uses deep learning (DL) to extract biomarkers from routine patho...
Background: Response to immunotherapy in gastric cancer is associated with microsatellite instabilit...
Artificial intelligence (AI) can predict the presence of molecular alterations directly from routine...
AbstractGastric cancer, a highly heterogeneous disease, is the second leading cause of cancer death ...
Background Response to immunotherapy in gastric cancer is associated with microsatellite instability...
In gastric cancer (GC), there are four molecular subclasses that indicate whether patients respond t...
This report describes an integrated study on identification of potential markers for gastric cancer ...
Deep learning (DL) can predict microsatellite instability (MSI) from routine histopathology slides o...
Gastric cancer is a leading cause of cancer deaths, but analysis of its molecular and clinical chara...
Molecular and genomic properties are critical in selecting cancer treatments to target individual tu...
Background: Determining the status of molecular pathways and key mutations in colorectal cancer is ...
Predicting responses to immune checkpoint blockade (ICB) lacks official standards despite the discov...
Background: Globally, gastric cancer (GC) is the fifth most common tumor. It is necessary to identif...
Molecular alterations in cancer can cause phenotypic changes in tumor cells and their microenvironme...
Aim Gastric cancer (GC) is a tumor entity with highly variant outcomes. Lymph node metastasis is a ...
BACKGROUND: Computational pathology uses deep learning (DL) to extract biomarkers from routine patho...
Background: Response to immunotherapy in gastric cancer is associated with microsatellite instabilit...
Artificial intelligence (AI) can predict the presence of molecular alterations directly from routine...
AbstractGastric cancer, a highly heterogeneous disease, is the second leading cause of cancer death ...
Background Response to immunotherapy in gastric cancer is associated with microsatellite instability...
In gastric cancer (GC), there are four molecular subclasses that indicate whether patients respond t...
This report describes an integrated study on identification of potential markers for gastric cancer ...
Deep learning (DL) can predict microsatellite instability (MSI) from routine histopathology slides o...
Gastric cancer is a leading cause of cancer deaths, but analysis of its molecular and clinical chara...
Molecular and genomic properties are critical in selecting cancer treatments to target individual tu...
Background: Determining the status of molecular pathways and key mutations in colorectal cancer is ...
Predicting responses to immune checkpoint blockade (ICB) lacks official standards despite the discov...
Background: Globally, gastric cancer (GC) is the fifth most common tumor. It is necessary to identif...
Molecular alterations in cancer can cause phenotypic changes in tumor cells and their microenvironme...
Aim Gastric cancer (GC) is a tumor entity with highly variant outcomes. Lymph node metastasis is a ...